HealthEquity Inc (HQY)
Days of sales outstanding (DSO)
Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 10.20 | 10.81 | 10.04 | 9.59 | 9.14 | 9.53 | 9.55 | 8.62 | 8.42 | 8.99 | 8.28 | 8.55 | 8.21 | 8.40 | 9.63 | 9.40 | 9.63 | 11.20 | 9.88 | 8.81 | |
DSO | days | 35.78 | 33.77 | 36.37 | 38.07 | 39.95 | 38.32 | 38.22 | 42.34 | 43.34 | 40.61 | 44.10 | 42.68 | 44.46 | 43.43 | 37.89 | 38.82 | 37.92 | 32.60 | 36.93 | 41.42 |
January 31, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 10.20
= 35.78
Days Sales Outstanding (DSO) is a key financial metric that measures how long it takes for a company to collect payment after making a sale. In the case of HealthEquity Inc, the DSO has shown some fluctuations over the periods analyzed.
From April 30, 2020, to July 31, 2021, the DSO exhibited a decreasing trend, indicating that HealthEquity was becoming more efficient in collecting its accounts receivable. However, in the subsequent periods up to July 31, 2024, there were fluctuations in the DSO, with some periods showing slight increases and decreases.
For instance, the DSO increased from October 31, 2021, to January 31, 2022, before decreasing slightly in the following period. This fluctuation continued until October 31, 2024, where a more significant decline was observed.
Overall, HealthEquity Inc's DSO has shown some variability over the periods analyzed, suggesting changes in the company's collection efficiency. It is important for management to monitor DSO closely to ensure efficient management of accounts receivable and cash flow.
Peer comparison
Jan 31, 2025